Search results for "AGENTS"

showing 10 items of 7330 documents

The effect of allergen immunotherapy in the onset of new sensitizations: a meta-analysis.

2017

Background Although the preventive efficacy of allergen immunotherapy (AIT) in the onset of new allergen sensitizations has been asserted by many reviews, position papers, and consensus conferences, the evidence available is from only 3 studies. The objective of this work was a systematic review to evaluate the preventive efficacy of AIT in the onset of new allergen sensitizations. The end-point was the risk difference (RD) in the onset of new allergen sensitizations between patients treated with AIT and pharmacotherapy. Methods Computerized bibliographic searches of MEDLINE, EMBASE, and the Cochrane Library (until November 30th, 2016) were done. Random-effects and fixed-effects model meta-…

allergic rhinitisPyroglyphidaenew allergen sensitizationasthmameta-analysiDesensitization ImmunologicAnti-Allergic Agentsallergen immunotherapyHypersensitivityAnimalsHumansImmunizationAntigens DermatophagoidesChildRandomized Controlled Trials as TopicInternational forum of allergyrhinology
researchProduct

Photocrosslinking of dextran and polyaspartamide derivatives: a combination suitable for colon-specific drug delivery.

2007

Abstract The aim of this study was to prepare and characterize novel hydrogels with polysaccharide–polyaminoacid structure, able to undergo an enzymatic hydrolysis in the colon and potentially useful for treating inflammatory bowel diseases (IBD). Starting materials were methacrylated dextran (DEX-MA) and methacrylated α,β-poly(N-2-hydroxyethyl)- dl -aspartamide (PHM). These polymers were photocrosslinked by exposure of their aqueous solutions at 313 nm without photoinitiators. Different samples, shaped as microparticles, were obtained as a function of polymer concentration and irradiation time. FT-IR analysis confirmed the occurrence of a co-crosslinking between DEX-MA and PHM in all exper…

alpha; beta-poly(n-2-hydroxyethyl)-dl-aspartamide; biodegradable hydrogels; colon drug delivery; dextran; photocrosslinking; α; β-poly(n-2-hydroxyethyl)-dl-aspartamidealphaCell SurvivalColonPhotochemistryDrug CompoundingαPharmaceutical ScienceDosage formchemistry.chemical_compoundDrug StabilityEnzymatic hydrolysismedicineCell AdhesionOrganic chemistryHumansParticle Sizeβ-poly(n-2-hydroxyethyl)-dl-aspartamideDrug CarriersChromatographyDextranaseAqueous solutionChemistryHydrolysisbiodegradable hydrogelstechnology industry and agriculturecolon drug deliveryBeclomethasoneMucinsDextransHydrogelsHydrogen-Ion ConcentrationDextranCross-Linking Reagentsbeta-poly(n-2-hydroxyethyl)-dl-aspartamidedextranDrug deliverySelf-healing hydrogelsMethacrylatesSwellingmedicine.symptomphotocrosslinkingCaco-2 CellsPeptidesJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Efficient synthesis of new C-functionalized macrocyclic polyamines

2010

A powerful synthetic route for the preparation of new poly-azamacrocycles, valuable precursors of bifunctional chelating agents with applications in nuclear medicine, is reported. The desired functional group was introduced onto the macro-cycle backbone during the cyclization step, thus avoiding the tedious preparation of a C-functionalized synthon. The regioselective reaction of macrocycles bearing an aminomethyl pendant arm with aldehydes is also described.

amines010402 general chemistry01 natural sciencesAldehydeChemical synthesischemistry.chemical_compoundN ligands[ CHIM.ORGA ] Chemical Sciences/Organic chemistryOrganic chemistryChelationPhysical and Theoretical ChemistryBifunctionalComputingMilieux_MISCELLANEOUSchemistry.chemical_classification010405 organic chemistryLigand[CHIM.ORGA]Chemical Sciences/Organic chemistryOrganic ChemistrySynthonRegioselectivity0104 chemical sciences3. Good healthmacrocycleschemistryFunctional groupbifunctional chelating agents
researchProduct

Ultrasound assisted method to increase soluble chemical oxygen demand (SCOD) of sewage sludge for digestion

2004

The aim of this study was to clarify the possibilities to increase the amount of soluble chemical oxygen demand (SCOD) and methane production of sludge using ultrasound technologies with and without oxidising agents. The study was done using multivariate data analyses. The most important factors affected were discovered. Ultrasonically assisted disintegration increased clearly the amount of SCOD of sludge. Also more methane was produced from treated sludge in anaerobic batch assays compared to the sludge with no ultrasonic treatment. Multivariate data analysis showed that ultrasonic power, dry solid content of sludge (DS), sludge temperature and ultrasonic treatment time have the most signi…

anaerobic digestionAcoustics and Ultrasonicssludge processingSonicationMethaneInorganic ChemistryBacteria AnaerobicSonicationchemistry.chemical_compoundBioreactorsOxygen ConsumptionSCODwastewater treatmenChemical Engineering (miscellaneous)Environmental ChemistryRadiology Nuclear Medicine and imagingSDG 7 - Affordable and Clean Energysludge disintegration/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energySewagesewage sludgebusiness.industryultrasoundsoluble chemical oxygen demandOrganic ChemistryUltrasoundChemical oxygen demandOxidantsPulp and paper industryRefuse DisposalOxygenAnaerobic digestionsludgeSolubilitychemistryoxidising agentsEnvironmental chemistrySCALE-UPUltrasonic sensorbusinessOxidation-ReductionSludgewastewatersUltrasonics Sonochemistry
researchProduct

Hsp60, a Novel Target for Antitumor Therapy: Structure-Function Features and Prospective Drugs Design

2013

Heat shock protein 60 kDa (Hsp60) is a chaperone classically believed to be involved in assisting the correct folding of other mitochondrial proteins. Hsp60 also plays a role in cytoprotection against cell stressors, displaying for example, antiapoptotic potential. Despite the plethora of studies devoted to the mechanism of Hsp60's function, especially in prokaryotes, fundamental issues still remain unexplored, including the definition of its role in cancer. Key questions still unanswered pertain to the differences in structure-function features that might exist between the well-studied prokaryotic GroEL and the largely unexplored eukaryotic Hsp60 proteins. In this article we discuss these …

animal structuresBinding pocketCellAntineoplastic Agentschemical and pharmacologic phenomenaComputational biologyBiologyBioinformaticsFunctional domaincomplex mixturesChaperoninStructure-Activity RelationshipNeoplasmsHeat shock proteinDrug DiscoverymedicineHumansPharmacologyCompound dockingSettore BIO/16 - Anatomia UmanaCell growthfungiSettore CHIM/06 - Chimica OrganicaChaperonin 60Hsp60Settore CHIM/08 - Chimica FarmaceuticaCytoprotectionGroELmedicine.anatomical_structureSettore CHIM/03 - Chimica Generale E InorganicaCancer treatmentDrug DesignChaperone (protein)biology.proteinHSP60Protein foldingEpolactaeneCurrent Pharmaceutical Design
researchProduct

Chaperonopathies and chaperonotherapy. Hsp60 as therapeutic target in cancer: potential benefits and risks.

2013

In this minireview we focus on Hsp60 as a target for anticancer therapy. We discuss the new concepts of chaperonopathies and chaperonotherapy and present information on Hsp60 localization in the cell membrane of human tumor cells. We describe novel mechanisms for Hsp60 reaching the extracellular environment that involve membrane-associated stages, as well as data on anti-Hsp60 antibodies found in human sera, both in normal subjects and patients affected by autoimmune diseases. Finally, we discuss possible therapeutic applications of anti-Hsp60 antibodies in cancer treatment, evaluating also side effects on non-tumor cells. In conclusion, the way for investigating Hsp60-targeted anti-tumor t…

animal structuresCellchemical and pharmacologic phenomenaAntineoplastic AgentsBiologycomplex mixturesRisk AssessmentCell membraneDrug Delivery SystemsRisk FactorsNeoplasmsDrug DiscoverymedicineExtracellularAnimalsHumansSecretionPharmacologyMechanism (biology)fungiCancerChaperonin 60medicine.diseasemedicine.anatomical_structureImmunologybiology.proteinCancer researchHsp60 Cpn60 HSPD1 plasma membrane antibodies autoantibodies antitumor immunotherapy anticancer therapy chaperonopathies human sera.HSP60AntibodyCurrent pharmaceutical design
researchProduct

External and internal elimination of supernumerary larvae in the whitefly parasitoid Eretmocerus mundus Mercet (Hymenoptera: Aphelinidae)

2008

Abstract The solitary parasitoid Eretmocerus mundus Mercet (Hymenoptera: Aphelinidae) is one of the key biological control agents of the whitefly Bemisia argentifolii Bellows & Perring, also known as B. tabaci (Gennadius) B-biotype (Homoptera: Aleyrodidae). We present new information on its biology, and particularly about larval elimination during the first instar in cases of superparasitism. For the first time, physical elimination of supernumerary larvae was observed, both outside and inside the host. These findings are documented with confocal microscopy images and video recordings. We observed more than 350 B. argentifolii nymphs, parasitized with one, two or more than two larvae. Physi…

animal structuresbiological-control agentsHomopteraZoologyHymenopteraWhiteflythelytocous eretmoceruslife-history parametersParasitoidbemisia-tabaciAphelinidaeinterspecific host discriminationLaboratory of EntomologyparthenogenesisEncarsia formosaLarvabiologyBemisia argentifolii attacco fisico eliminazione di larve sopranumerarie Wolbachia superparassitismoEcologyfungiwaspsbiology.organism_classificationPE&RCLaboratorium voor EntomologieSettore AGR/11 - Entomologia Generale E ApplicataaleyrodidaeInsect ScienceInstarencarsia-formosaAgronomy and Crop Sciencecompetition
researchProduct

Design, synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones

2003

anti-HIV agents
researchProduct

New 1,2,4-oxadiazole nortopsentin derivatives with cytotoxic activity

2019

New analogs of nortopsentin, a natural 2,4-bis(3&prime

anti-cancer agentCell SurvivalAnti-cancer agentsPharmaceutical ScienceAntineoplastic AgentsAntiproliferative activity01 natural sciencesArticlechemistry.chemical_compoundStructure-Activity RelationshipMarine alkaloidsSettore BIO/10 - BiochimicaDrug DiscoveryMoietyHumansPharmacology Toxicology and Pharmaceutics (miscellaneous)lcsh:QH301-705.5Cell ProliferationIndole testMolecular Structure010405 organic chemistryAcridine orangeImidazoles2 4-oxadiazole derivativesnortopsentin analogs2 4-oxadiazole derivatives; Anti-cancer agents; Antiproliferative activity; Marine alkaloids; Nortopsentin analogs 1; Antineoplastic Agents; Caco-2 Cells; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; HCT116 Cells; Humans; Imidazoles; MCF-7 Cells; Molecular Structure; Structure-Activity RelationshipPhosphatidylserineCell Cycle CheckpointsNortopsentin analogs 1HCT116 CellsSettore CHIM/08 - Chimica Farmaceutica0104 chemical sciences124-oxadiazole derivative010404 medicinal & biomolecular chemistrychemistryBiochemistry124-oxadiazole derivativeslcsh:Biology (General)ApoptosisCell cultureCancer cellMCF-7 CellsMarine alkaloid2 4-oxadiazole derivativeCaco-2 CellsEthidium bromide
researchProduct

Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade

2022

Objective: To analyze, in a cohort of pediatric patients with recurrent pericarditis undergoing anti-interleukin (IL)-1 treatment: the agent and dosing used as first-line treatment, the long-term efficacy of IL-1 blockers, the percentage of patients achieving a drug-free remission, and the presence of variables associated with drug-free remission. Study design: Data were collected from patients' charts. The annualized relapse rate (ARR) was used for evaluation of treatment efficacy, and bivariate logistic regression analysis was used for variables associated with drug-free remission. Results: Fifty-eight patients, treated between 2008 and 2018, were included in the study (mean follow-up. 2.…

anti-inflammatory agents nonsteroidal colchicine interleukin-1 pericarditis steroids therapytherapySettore MED/38 - Pediatria Generale E SpecialisticaSettore MED/09 - Medicina Internaanti-inflammatory agents non-steroidal; colchicine; interleukin-1; pericarditis; steroids; therapyanti-inflammatory agents nonsteroidalanti-inflammatory agents non-steroidalPediatrics Perinatology and Child Healthanti-inflammatory agents nonsteroidal; colchicine; interleukin-1; pericarditis; steroids; therapypericarditiscolchicineinterleukin-1steroidsThe Journal of Pediatrics
researchProduct